Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLRA1 | P23415 | 1/20 | 0.32 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.32 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8935122 | 0.69 | LMNA (0.37) | ALDH1A1TSHRFGFR4 | |
| SCHEMBL9573116 | 0.67 | ALDH1A1 (0.40) | ALDH1A1TSHRFGFR4 | |
| SCHEMBL801097 | 0.63 | GLRA1 (0.37) | GLRA1SLC6A9OR51E2 | |
| SCHEMBL9642490 | 0.63 | — | — | |
| SCHEMBL7205332 | 0.63 | GLRA1 (0.37) | GLRA1SLC6A9OR51E2 | |
| SCHEMBL7864319 | 0.61 | GLRA1 (0.42) | GLRA1SLC6A9OR51E2ALDH1A1 | |
| Vinyl Ether SCHEMBL5600513 | 0.59 | GLRA1 (0.56) | GLRA1SLC6A9OR51E2ALDH1A1TSHR | |
| SCHEMBL451714 | 0.59 | — | — | |
| SCHEMBL1843588 | 0.59 | — | — | |
| SCHEMBL4953695 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3141615-B1 | REAL-TIME NUCLEIC ACID DETECTION PROCESSES AND COMPOSITIONS | ENZO LIFE SCIENCES INC (US) | 2019-10-23 | — | — | EP | disclosed |
| US-20190048401-A1 | OPTIMIZED REAL-TIME NUCLEIC ACID DETECTION PROCESSES | ENZO LIFE SCIENCES, INC. (US) | 2019-02-14 | — | — | US | disclosed |
| EP-1348713-B1 | Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses | ENZO LIFE SCIENCES INC (US) | 2019-01-23 | — | — | EP | disclosed |
| US-10144957-B2 | Optimized real time nucleic acid detection processes | ENZO LIFE SCIENCES, INC. (US) | 2018-12-04 | — | — | US | disclosed |
| US-10144956-B2 | Processes for quantitative or qualitative detection of single-stranded or double-stranded nucleic acids | ENZO BIOCHEM, INC. (US) | 2018-12-04 | — | — | US | disclosed |
| EP-2366798-B1 | Nucleic acid detection process involving energy transfer labels on nucleotide | ENZO LIFE SCIENCES INC (US) | 2017-06-28 | — | — | EP | disclosed |
| EP-1344835-B1 | REAL-TIME NUCLEIC ACID DETECTION PROCESSES AND COMPOSITIONS | ENZO LIFE SCIENCES INC (US) | 2017-06-14 | — | — | EP | disclosed |
| EP-3141615-A1 | REAL-TIME NUCLEIC ACID DETECTION PROCESSES AND COMPOSITIONS | Enzo Life Sciences, Inc. (US) | 2017-03-15 | — | — | EP | disclosed |
| US-20160281146-A1 | OPTIMIZED REAL TIME NUCLEIC ACID DETECTION PROCESSES | ENZO LIFE SCIENCES, INC. (US) | 2016-09-29 | — | — | US | disclosed |
| US-20160273028-A1 | PROCESSES FOR QUANTITATIVE OR QUALITATIVE DETECTION OF SINGLE-STRANDED OR DOUBLE-STRANDED NUCLEIC ACIDS | ENZO LIFE SCIENCES, INC. (US) | 2016-09-22 | — | — | US | disclosed |
| US-20050004350-A1 | Novel chemiluminescent reagents | ENZO LIFE SCIENCES, INC. (US) | 2005-01-06 | — | — | US | disclosed |
| US-20040254355-A1 | Labeling reagents comprising aphenylic analogs of rhodamine dyes | ENZO LIFE SCIENCES, INC. | 2004-12-16 | — | — | US | disclosed |
| US-20040229248-A1 | Novel dye labeling composition | ENZO LIFE SCIENCES, INC. | 2004-11-18 | — | — | US | disclosed |
| US-20040230036-A1 | Heterodimeric dye composition | ENZO LIFE SCIENCES, INC. (US) | 2004-11-18 | — | — | US | disclosed |
| US-20040203038-A1 | Process for preparing novel cyanine dye labeling reagents | ENZO LIFE SCIENCES, INC. | 2004-10-14 | — | — | US | disclosed |
| US-20040192893-A1 | comprises cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes for use in labeling nucleic acids or proteins in assay, and as diagnostic aid in genomics/proteomics | ENZO LIFE SCIENCES, INC. (US) | 2004-09-30 | — | — | US | disclosed |
| US-20040176586-A1 | Process for detecting the presence or quantity of enzymatic activity in a sample | ENZO LIFE SCIENCES, INC. (US) | 2004-09-09 | — | — | US | disclosed |
| US-20030225247-A1 | Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses | ENZO LIFE SCIENCES, INC. | 2003-12-04 | — | — | US | disclosed |
| EP-1348713-A2 | Labeling reagents and labeled tabeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses | Enzo Life Sciences, Inc. (US) | 2003-10-01 | — | — | EP | disclosed |
| EP-1344835-A2 | Real-time nucleic acid detection processes and compositions | Enzo Life Sciences, Inc. (US) | 2003-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040229248-A1 | Novel dye labeling composition | IK, PHAX, CHLSN | GLRA1 4156/4885SLC6A9 4731/4885OR51E2 2682/4885 |
| US-20040203038-A1 | Process for preparing novel cyanine dye labeling reagents | PHAX, IK, CHLSN | GLRA1 4264/4885SLC6A9 4692/4885OR51E2 3174/4885 |
| US-20050004350-A1 | Novel chemiluminescent reagents | CHLSN, CYBA, HLCS | GLRA1 4155/4885SLC6A9 4817/4885OR51E2 2271/4885 |
| US-20040176586-A1 | Process for detecting the presence or quantity of enzymatic activity in a sample | RNGTT, POLRMT, CHLSN | GLRA1 4552/4885SLC6A9 4709/4885OR51E2 3158/4885 |
| US-20040230036-A1 | Heterodimeric dye composition | IK, CHLSN, CRY2 | GLRA1 3440/4885SLC6A9 4556/4885OR51E2 2355/4885 |
| US-20030225247-A1 | Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses | POLRMT, CHLSN, PHAX | GLRA1 3865/4885SLC6A9 4543/4885OR51E2 2255/4885 |
| US-20040254355-A1 | Labeling reagents comprising aphenylic analogs of rhodamine dyes | IK, RBM25, CHLSN | GLRA1 2615/4885SLC6A9 4774/4885OR51E2 1588/4885 |
| US-20040192893-A1 | comprises cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes for use in labeling nucleic acids or proteins in assay, and as diagnostic aid in genomics/proteomics | CHLSN, DDB1, PROC | GLRA1 4308/4885SLC6A9 4620/4885OR51E2 3364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.